These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 18684027)

  • 1. An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology.
    Chetty R
    Arch Pathol Lab Med; 2008 Aug; 132(8):1285-9. PubMed ID: 18684027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract.
    Rindi G; Capella C; Solcia E
    Q J Nucl Med; 2000 Mar; 44(1):13-21. PubMed ID: 10932598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors.
    Rindi G; Villanacci V; Ubiali A
    Digestion; 2000; 62 Suppl 1():19-26. PubMed ID: 10940683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
    Janson ET; Sorbye H; Welin S; Federspiel B; Grønbæk H; Hellman P; Ladekarl M; Langer SW; Mortensen J; Schalin-Jäntti C; Sundin A; Sundlöv A; Thiis-Evensen E; Knigge U
    Acta Oncol; 2014 Oct; 53(10):1284-97. PubMed ID: 25140861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification.
    Klöppel G; Perren A; Heitz PU
    Ann N Y Acad Sci; 2004 Apr; 1014():13-27. PubMed ID: 15153416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Classification of Gastrointestinal and Pancreatic Neuroendocrine Neoplasms: Are We Ready for That?
    Uccella S
    Endocr Pathol; 2024 Jun; 35(2):91-106. PubMed ID: 38470548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.
    Klöppel G
    Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Standardization in pathologic diagnosis of gastrointestinal and pancreatic neuroendocrine tumors].
    Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):793-5. PubMed ID: 21215092
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors.
    Asa SL; La Rosa S; Basturk O; Adsay V; Minnetti M; Grossman AB
    Endocr Pathol; 2021 Mar; 32(1):169-191. PubMed ID: 33459926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the cytologic diagnosis of gastroenteropancreatic neuroendocrine neoplasms.
    Sigel CS
    Cancer Cytopathol; 2018 Dec; 126(12):980-991. PubMed ID: 30485690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gastroenteropancreatic neuroendocrine neoplasms. Role of biopsies].
    Bergmann F
    Pathologe; 2013 Nov; 34 Suppl 2():221-5. PubMed ID: 24196617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic criteria and classification of gastro-intestinal pancreatic endocrine tumors].
    Capella C; Uccella S; Albarello L; Feltri M; La Rosa S
    Minerva Endocrinol; 2001 Sep; 26(3):103-10. PubMed ID: 11753231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine tumors of the gut and pancreas tumor biology and classification.
    Rindi G; Klöppel G
    Neuroendocrinology; 2004; 80 Suppl 1():12-5. PubMed ID: 15477709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Approach to Neuroendocrine Neoplasms of the Gastrointestinal Tract and Pancreas.
    Uccella S; Sessa F; La Rosa S
    Turk Patoloji Derg; 2015; 31 Suppl 1():113-27. PubMed ID: 26177322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poorly differentiated gastroenteropancreatic neuroendocrine carcinoma associated with X-linked hyperimmunoglobulin M syndrome.
    Malhotra RK; Li W
    Arch Pathol Lab Med; 2008 May; 132(5):847-50. PubMed ID: 18466034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases.
    Schmitt AM; Riniker F; Anlauf M; Schmid S; Soltermann A; Moch H; Heitz PU; Klöppel G; Komminoth P; Perren A
    Am J Surg Pathol; 2008 Mar; 32(3):420-5. PubMed ID: 18300808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What is new in the pathology of pancreatic neuroendocrine tumors?].
    Komminoth P; Perren A
    Pathologe; 2015 May; 36(3):220-8. PubMed ID: 25941099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The ENETS and UICC TNM classification of neuroendocrine tumors of the gastrointestinal tract and the pancreas: comment].
    Klöppel G; Rindi G; Perren A; Komminoth P; Klimstra DS
    Pathologe; 2010 Sep; 31(5):353-4. PubMed ID: 20809402
    [No Abstract]   [Full Text] [Related]  

  • 19. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH; Basturk O; Sue JJ; Klimstra DS
    Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and Cell Biological Aspects of Gastroenteropancreatic Neuroendocrine Tumor Disease. Conference proceedings. Berlin, Germany, November 3-7, 1993.
    Ann N Y Acad Sci; 1994 Sep; 733():1-535. PubMed ID: 7978857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.